493 related articles for article (PubMed ID: 21097819)
1. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy.
Lehrke S; Lossnitzer D; Schöb M; Steen H; Merten C; Kemmling H; Pribe R; Ehlermann P; Zugck C; Korosoglou G; Giannitsis E; Katus HA
Heart; 2011 May; 97(9):727-32. PubMed ID: 21097819
[TBL] [Abstract][Full Text] [Related]
2. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis.
Shi HW; Pu P; Deng W; Zhou H; Bian ZY; Shen DF; Xie J; Salerno M; Tang QZ
Saudi Med J; 2013 Jul; 34(7):719-26. PubMed ID: 23860892
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
[TBL] [Abstract][Full Text] [Related]
8. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of late gadolinium enhancement by cardiac magnetic resonance imaging in patients with non-ischaemic dilated cardiomyopathy.
Li X; Chan CP; Hua W; Ding L; Wang J; Zhang S; Li S; Zhang Y
Int J Cardiol; 2013 Oct; 168(5):4979-80. PubMed ID: 23911271
[No Abstract] [Full Text] [Related]
10. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
[TBL] [Abstract][Full Text] [Related]
12. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of late gadolinium enhancement in a cohort of patients with nonischemic dilated cardiomyopathy.
Rodríguez-Capitán J; García-Pinilla JM; Ruiz-Zamora I; Rueda-Calle E; Morcillo-Hidalgo L; Jurado-Canca C; Robledo-Carmona J; Gómez-Doblas JJ; de Teresa-Galván E
Int J Cardiol; 2014 Nov; 177(1):17-9. PubMed ID: 25499325
[No Abstract] [Full Text] [Related]
15. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
16. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
17. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy.
Akisawa M; Matsumura Y; Kitaoka H; Yamasaki N; Takata J; Doi Y
J Cardiol; 2002 Oct; 40(4):145-52. PubMed ID: 12420668
[TBL] [Abstract][Full Text] [Related]
18. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM
Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651
[TBL] [Abstract][Full Text] [Related]
20. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
